BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 250 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,000 | -77.8% | 10 | -83.3% | 0.00% | -100.0% |
| Q2 2022 | $9,000 | -87.1% | 60 | -89.8% | 0.00% | -88.9% |
| Q1 2022 | $70,000 | -13.6% | 587 | 0.0% | 0.01% | -10.0% |
| Q4 2021 | $81,000 | +24.6% | 587 | +25.4% | 0.01% | +11.1% |
| Q3 2021 | $65,000 | +85.7% | 468 | +31.1% | 0.01% | +80.0% |
| Q2 2021 | $35,000 | +3400.0% | 357 | +3470.0% | 0.01% | – |
| Q1 2021 | $1,000 | 0.0% | 10 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | – | 10 | +66.7% | 0.00% | – |
| Q2 2020 | $0 | – | 6 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 490,422 | $12,755,876 | 13.24% |
| FNY Investment Advisers, LLC | 30 | $0 | 0.00% |